CLMT vs DRD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLMT shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Concerns include weak profitability or high valuation.
DRD exhibits exceptional fundamental health, highlighted by a strong Piotroski F-Score of 8/9 and a pristine balance sheet with zero debt. While the stock trades at a premium to its Graham Number ($16.31), it remains significantly undervalued relative to its intrinsic value ($46.32) and analyst target price ($46.50). High profitability margins and an impressive ROE of 34.71% suggest a highly efficient operation. Despite a bearish technical trend and weak insider sentiment, the underlying financial strength and growth trajectory provide a compelling bullish case.
Compare Another Pair
Related Comparisons
CLMT vs DRD: Head-to-Head Comparison
This page compares Calumet, Inc. (CLMT) and DRDGOLD Limited (DRD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.